Coupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation

Pharmaceutical biodegradation can generate potentially toxic metabolites that persist after the parent compound has been removed, posing additional risks to aquatic environments. Microbial co-cultures offer a promising strategy to address this challenge by combining complementary metabolic capabilities to remove both pharmaceuticals and their harmful transformation products by coupling complementary degradation pathways. Here, we investigated a two-species co-culture combining the paracetamol-degrading bacterium Delftia P1 with Microbacterium lacus to enable subsequent 4-AP removal. While Delftia P1 efficiently degraded paracetamol, it accumulated 4-AP as a dead-end metabolite. M. lacus was selected to complement this metabolic limitation because its genome contains a homolog of sadB, a monooxygenase gene involved in 4-AP transformation. The relative abundance of the two strains strongly influenced 4-AP removal, with the highest efficiency achieved at a Delftia P1:M. lacus cell-density ratio of 1:100, corresponding to an OD600nm ratio of 1:10. At this ratio, the co-culture achieved complete removal of paracetamol and 4-AP within 6 and 24 h, respectively. Its capacity was tested in wastewater, where 100% of paracetamol were removed within 4 h and no accumulation of 4-AP was observed within 24 h. These findings demonstrate the potential of cocultivating bacteria with complementary metabolic capabilities to address both pharmaceutical contamination and transformation-product accumulation. Moreover, the highest 4-AP removal was achieved when M. lacus was present at a 100-fold higher cell density than Delftia P1, highlighting the importance of considering relative cell densities when designing co-cultures.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.11.765863
Primary Topic
Pharmaceutical and Antibiotic Environmental Impacts
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Coupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation

Pilar Junier, Philippe F.-X. Corvini, Marcel Suleiman, Cristina Zimmardi et al.
1 links
bioRxiv (Cold Spring Harbor Laboratory)
Pharmaceutical and Antibiotic Environmental Impacts
preprint

Coupling Complementary Pathways in a Bacterial Co-culture Enables 4-Aminophenol Removal during Paracetamol Degradation

Pilar Junier, Philippe F.-X. Corvini, Marcel Suleiman, Cristina Zimmardi, Francesca Demaria, Matthias Schaffter
preprint en

Abstract

Pharmaceutical biodegradation can generate potentially toxic metabolites that persist after the parent compound has been removed, posing additional risks to aquatic environments. Microbial co-cultures offer a promising strategy to address this challenge by combining complementary metabolic capabilities to remove both pharmaceuticals and their harmful transformation products by coupling complementary degradation pathways. Here, we investigated a two-species co-culture combining the paracetamol-degrading bacterium Delftia P1 with Microbacterium lacus to enable subsequent 4-AP removal. While Delftia P1 efficiently degraded paracetamol, it accumulated 4-AP as a dead-end metabolite. M. lacus was selected to complement this metabolic limitation because its genome contains a homolog of sadB, a monooxygenase gene involved in 4-AP transformation. The relative abundance of the two strains strongly influenced 4-AP removal, with the highest efficiency achieved at a Delftia P1:M. lacus cell-density ratio of 1:100, corresponding to an OD600nm ratio of 1:10. At this ratio, the co-culture achieved complete removal of paracetamol and 4-AP within 6 and 24 h, respectively. Its capacity was tested in wastewater, where 100% of paracetamol were removed within 4 h and no accumulation of 4-AP was observed within 24 h. These findings demonstrate the potential of cocultivating bacteria with complementary metabolic capabilities to address both pharmaceutical contamination and transformation-product accumulation. Moreover, the highest 4-AP removal was achieved when M. lacus was present at a 100-fold higher cell density than Delftia P1, highlighting the importance of considering relative cell densities when designing co-cultures.

bioRxiv (Cold Spring Harbor Laboratory)
FHNW University of Applied Sciences and Arts Northwestern Switzerland (CH)
European Commission, HORIZON EUROPE Framework Programme, Staatssekretariat für Bildung, Forschung und Innovation
Clean water and sanitation
Pharmaceutical and Antibiotic Environmental Impacts
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon